Cargando…

Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus‐based cervical screening program: A cross‐sectional survey

OBJECTIVE: To examine the impact of self‐reported human papillomavirus (HPV) test result (HPV negative, HPV positive, HPV result unknown) on a range of psychosocial outcomes. METHODS: Women and other people with a cervix in Australia aged 25–74 years who reported having participated in cervical scre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chadwick, Verity, Bennett, Kirsty F., McCaffery, Kirsten J., Brotherton, Julia M. L., Dodd, Rachael H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546150/ https://www.ncbi.nlm.nih.gov/pubmed/35128756 http://dx.doi.org/10.1002/pon.5897

Ejemplares similares

Knowledge of human papillomavirus (HPV) testing in the USA, the UK and Australia: an international survey
por: Dodd, Rachael H, et al.
Publicado: (2014)

Women’s experiences of the renewed National Cervical Screening Program in Australia 12 months following implementation: a qualitative study
por: Dodd, Rachael H, et al.
Publicado: (2020)

A Thematic Analysis of Attitudes Toward Changes to Cervical Screening in Australia
por: Dodd, Rachael H, et al.
Publicado: (2019)

Implementation of Australia’s primary human papillomavirus (HPV) cervical screening program: The STakeholders Opinions of Renewal Implementation and Experiences Study
por: Brotherton, Julia M.L., et al.
Publicado: (2023)

Factors associated with the human papillomavirus (HPV) vaccination across three countries following vaccination introduction
por: Nickel, Brooke, et al.
Publicado: (2017)

Effect of a School-Based Educational Intervention About the Human Papillomavirus Vaccine on Psychosocial Outcomes Among Adolescents: Analysis of Secondary Outcomes of a Cluster Randomized Trial
por: Davies, Cristyn, et al.
Publicado: (2021)

Examining the information needed for acceptance of deintensified screening programmes: qualitative focus groups about cervical screening in Australia
por: Dodd, Rachael H, et al.
Publicado: (2019)

‘It has saved thousands of lives, so why change it?’ Content analysis of objections to cervical screening programme changes in Australia
por: Obermair, Helena M, et al.
Publicado: (2018)

Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia
por: Crowe, Elizabeth, et al.
Publicado: (2014)

Getting the timing right: Women’s views on the best time to announce changes to cancer screening policy recommendations
por: Dodd, Rachael H., et al.
Publicado: (2020)

Human papillomavirus testing in cervical cancer screening
por: Franceschi, S, et al.
Publicado: (2005)

Awareness of human papillomavirus among women attending a well woman clinic
por: Waller, J, et al.
Publicado: (2003)

Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile
por: Brebi, Priscilla, et al.
Publicado: (2017)

Effect of different communication strategies about stopping cancer screening on screening intention and cancer anxiety: a randomised online trial of older adults in Australia
por: Smith, Jenna, et al.
Publicado: (2020)

Cervical Human Papillomavirus Screening among Older Women
por: Grainge, Matthew J., et al.
Publicado: (2005)

Human Papillomavirus and Cervical Cancer
por: Unger, Elizabeth R., et al.
Publicado: (2004)

Willingness to vaccinate against COVID-19 in Australia
por: Dodd, Rachael H, et al.
Publicado: (2021)

Association between human papillomavirus vaccine status and other cervical cancer risk factors
por: Bowyer, Harriet L., et al.
Publicado: (2014)

Psychosocial impact of human papillomavirus‐related head and neck cancer on patients and their partners: A qualitative interview study
por: Dodd, Rachael H., et al.
Publicado: (2019)

Exploring the psychosexual impact and disclosure experiences of women testing positive for high‐risk cervical human papillomavirus
por: Bennett, Kirsty F., et al.
Publicado: (2022)

Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan
por: Sasaki, Yuri, et al.
Publicado: (2017)

Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea
por: Kim, Mee-seon, et al.
Publicado: (2020)

Quality assurance in human papillomavirus testing for primary cervical screening
por: Cuschieri, Kate, et al.
Publicado: (2023)

The psychosexual impact of testing positive for high‐risk cervical human papillomavirus (HPV): A systematic review
por: Bennett, Kirsty F., et al.
Publicado: (2019)

Psychological Wellbeing and Academic Experience of University Students in Australia during COVID-19
por: Dodd, Rachael H., et al.
Publicado: (2021)

Involvement of Human Papillomaviruses in Cervical Cancer
por: Wang, Xuelian, et al.
Publicado: (2018)

The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
por: Patel, Cyra, et al.
Publicado: (2018)

Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping
por: Ge, Shichao, et al.
Publicado: (2012)

Human Papillomavirus Types Distribution in Organised Cervical Cancer Screening in France
por: Heard, Isabelle, et al.
Publicado: (2013)

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?
por: Castañon, Alejandra, et al.
Publicado: (2018)

Evaluation of human-papillomavirus screening for cervical cancer in China’s rural population
por: Li, Ling, et al.
Publicado: (2019)

Validation of the cobas 6800 human papillomavirus test in primary cervical screening
por: Sundström, Karin, et al.
Publicado: (2021)

Human papillomavirus testing as a primary screening tool for cervical cancer
por: Cho, Hyun-Woong, et al.
Publicado: (2021)

Participatory innovation for human papillomavirus screening to accelerate the elimination of cervical cancer
por: Rodriguez, Natalia M
Publicado: (2021)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs
por: Gupta, Sarah, et al.
Publicado: (2018)

Evaluating Human Papillomavirus Vaccination Programs
por: Taira, Al V., et al.
Publicado: (2004)

Women’s intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program
por: Smith, Laurie W, et al.
Publicado: (2014)

Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region()
por: Castellsagué, Xavier, et al.
Publicado: (2016)

Human papillomavirus and invasive cervical cancer in Brazil.
por: Eluf-Neto, J., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_3k3ha586bm0idacgf58blen7vc